PubMed · 2006 · 74 citations · 0 references
MedicineImmunologyPharmacotherapyImmunopathologyInflammationRheumatologyAnti-inflammatory PharmacologyImmune-mediated Inflammatory DiseasesInflammatory ArthritisInterstitial Lung DiseasePulmonary InflammationRheumatoid ArthritisDrug-induced PneumonitisDrug-related PneumonitisImmunotherapy-related PneumonitisInterstitital Lung DiseasePulmonary Toxicity MechanismsRheumatoid Arthritis Pharmacotherapy
Interstitial pneumonitis is a well documented, rare complication of methotrexate (MTX). We describe a patient with rheumatoid arthritis (RA) taking MTX for more than 3 years who then developed severe interstitial pneumonitis after a third infliximab infusion. Other similar cases are reviewed. Infliximab may potentiate pulmonary toxicity of MTX.